3
Announcements
Trials
Browse
Landscape
Status
Recruiting
21
Active not recruiting
8
Not yet recruiting
6
Terminated
4
Completed
4
Enrolling by invitation
2
Suspended
1
Available
1
Sponsor Class
OTHER
1
Study Type
Expanded_access
1
Sponsor
Conditions
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
6
Sarcoma
5
Prostatic Neoplasms
5
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Neuroblastoma
4
Multiple Myeloma
4
Breast Neoplasms
4
Melanoma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myeloid, Acute
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Primary Myelofibrosis
2
Osteosarcoma
2
Non-Muscle Invasive Bladder Neoplasms
2
Neuroectodermal Tumors, Primitive
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma
2
Insulinoma
2
Hypoglycemia
2
Hyperinsulinism
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Available
×
Epstein-Barr Virus Infections
×
1 year
×
Clear all
NCT07104591
2025-08-05
TETRAVI Expanded Access Program
Baylor College of Medicine
Available